跳至主要内容
临床试验/NCT02494648
NCT02494648已完成不适用

Effects of Inspiratory Muscles Strengthening Among Coronary Patients on the Sleep Apnea Obstructive Syndrome (SAOS)

Centre Hospitalier Universitaire de Saint Etienne1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2015年5月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
AHI Variation

研究概览

简要总结

Obstructive sleep apnea (OSA) syndrome affects up to 5% of the general population. The prevalence is multiplied by 13 in coronary artery disease (CAD) patients. Many studies have shown that OSA syndrome was the main risk factor for cardiovascular morbidity and mortality (RR = 9.1 [95%, 2.6 to 31.2]).

If the value of treatment with Continuous Positive Airway Pressure (CPAP) in symptomatic CAD patients (daytime sleepiness and/or 2 clinical symptoms with Apnea Hypopnea Index (AHI) ≥ 20) appears to be established, treatment with CPAP in asymptomatic CAD patients (with AHI> 30) may be too demanding. Alternative treatments are rare and results are highly variable. Therefore, it would be interesting to suggest other treatment modalities with moderate coronary and/or minimally symptomatic OSA syndrome.

详细描述

This study aims to assess the relevance of inspiratory muscles strengthening on reducing AHI in CAD patients with moderate OSA (AHI between 15 and 30).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with moderate OSA (15 <AHI <30)
  • •Period between acute coronary syndrome and inclusion <60 days
  • •Patients included in cardiac rehabilitation

排除标准

  • •Obstructive lung disease with Tiffeneau index less than 70%.
  • •Restrictive lung disease with a reduction of total lung capacity (TLC)
  • •Treatment for OSA or clinical context (comorbidity) justifying CPAP
  • •Congestive heart failure, thoracic surgery by sternotomy
  • •Spontaneous pneumothorax
  • •Severe Asthma
  • •Ruptured eardrum, or another disease of the middle ear, or acute sinusitis

研究组 & 干预措施

Inspiratory muscles strengthening

Experimental

The device used is : POWERbreathe Fitness Plus, (POWERbreathe International Ltd, UK).

Class I, CE labelled. POWERbreathe fitness Plus uses the technique of training against resistance to increase the strength, the power and the endurance of the respiratory muscles (diaphragm and rib cage).

干预措施: POWERbreathe Fitness Plus, (POWERbreathe International Ltd, UK) [Inspiratory muscles strengthening] (Device)

Control

Placebo Comparator

No intervention

干预措施: Control (Other)

结局指标

主要结局

AHI Variation

时间窗: At 6 weeks

It is the difference between the AHI at the inclusion et the AHI at 6 weeks

次要结局

  • Circumference of the neck in centimetre(At 6 weeks)
  • Epworth questionnaire to evaluate the deficit of sleep(at 6 weeks)
  • Pittsburgh questionnaire to evaluate the quality of sleep(At 6 weeks)
  • SF12 questionnaire to evaluate the quality of life(At 6 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验